profit from every ₹100 of sales.
₹0₹100
Max Healthcare Institute
₹928.30+1.45% today
-13.5% in 1 year
1-year low ₹815.001-year high ₹1,153.40
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹62.64 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Max Healthcare Institute sold, what it kept, and what it did with the cash.
Sales went from ₹44.9 billion in 2023 to ₹83.7 billion in 2026, with ₹14.4 billion of profit last year.
SalesProfit
Max Healthcare Institute handed back 98% of the cash it generated last year.
₹1.5B
Free cash flow 2026₹1.5B
Bought back its own shares–
Paid as dividends₹1.5B
Cash vs. debt₹6.7B vs. ₹34.8B
Max Healthcare Institute vs. similar companies
Max Healthcare Institute grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| Max Healthcare Institute | 62.6× · Very expensive | ||
 HCA Healthcare | 15.6× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.5× · Fair price | ||
 IHH Healthcare Berhad | 33.4× · Expensive | ||
 Rede D'Or São Luiz | 15.9× · Fair price |
AI analysis
An AI analyst reads Max Healthcare Institute's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 44,890 | 53,095 | 70,285 | 83,735 | |
| 35,679 | 41,915 | 55,514 | 65,834 | |
| 10,452 | 12,846 | 14,894 | 17,963 | |
| 13,672 | 16,549 | 19,308 | 23,572 | |
| 11,035 | 10,576 | 10,759 | 14,424 | |
| 11.36 | 10.84 | 11.01 | – | |
| 79.5% | 78.9% | 79.0% | 78.6% | |
| 23.3% | 24.2% | 21.2% | 21.5% | |
| 24.6% | 19.9% | 15.3% | 17.2% |
Balance sheet
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 101,019 | 119,999 | 152,145 | 172,309 |
| Cash | 13,743 | 9,798 | 6,616 | 6,658 |
| Total debt | 9,083 | 12,946 | 30,103 | 34,784 |
| Total liabilities | 26,923 | 35,918 | 58,336 | 64,843 |
| 74,096 | 84,081 | 93,809 | 107,466 | |
| 972 | 975 | 977 | – | |
| 10.2% | 10.9% | 9.5% | 10.1% | |
| 14.9% | 12.6% | 11.5% | 13.4% |
Cash flow
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 12,841 | 11,217 | 14,380 | 16,333 | |
| 3,356 | 7,860 | 9,445 | 14,845 | |
| 9,485 | 3,357 | 4,935 | 1,488 | |
| Dividends paid | – | 970 | 1,456 | 1,456 |
| – | – | – | – | |
| 344 | 496 | 546 | 483 |
Valuation
- 62.6×
- –
- –
- 8.7×
- 10.8×
- 607.3×
- 39.5×
- 0.2%
- 1.6%
- 0.2%
Profitability
- 78.6%
- 21.5%
- 17.2%
- –
- 10.1%
- 10.2%
- –
- –
- –
- –
Growth
- +23.1%
- –
- –
- –
- +0.3%
Financial health
- 1.2×
- 0.32
- –
- 8.1×
- 0.89
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 30%of 958
Top 20%of 888
Bottom 18%of 600
Top 24%of 889
Bottom 41%of 987
0.2%of the share price, paid each year
On $1,000 invested$2a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
10.1% of its profit
Room to growStretchedMore than it earns: 97.9%
News
Gabelli Healthcare & Wellness Trust raises dividend by 17.6% to $0.20Seeking Alpha · Nov 11, 2026Healthcare Just Hit a Record Lead Over Tech. 3 Things Could Shrink ItYahoo Finance · Nov 11, 2026Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focusSeeking Alpha · Nov 8, 2026The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?Yahoo Finance · Nov 7, 2026American Healthcare REIT forecasts $2.23-$2.26 2026 NFFO per share as same-store NOI growth target rises to 12%-14%Seeking Alpha · Nov 6, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
45No pass
Benjamin Graham
33No pass
Philip Fisher
55No pass
Peter Lynch
92Pass
Joel Greenblatt
9No pass
Charlie Munger
40No pass
Terry Smith
32No pass
Questions about Max Healthcare Institute
Is Max Healthcare Institute a good stock to buy?
A solid business, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Max Healthcare Institute AI analysis
What does Max Healthcare Institute do?
Max Healthcare Institute Limited provides medical and healthcare services in India. It is in Medical Care Facilities, based in Gurugram, India.
Does Max Healthcare Institute pay a dividend?
Yes. At today's price the dividend is 0.2% a year, about 10% of its yearly profit. In 2026 it paid out ₹1.46 billion in dividends.
Is Max Healthcare Institute stock halal?
Yes. Max Healthcare Institute passes our halal screen: its business is permitted and its debt is 4% of its market value, under the 30% limit. How we check
How has Max Healthcare Institute stock done over the past year?
Down 13.5% over the past twelve months, to ₹928.30. It traded between ₹815.00 and ₹1,153.40 and is 19.5% below its high.
Who are Max Healthcare Institute's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with Max Healthcare Institute's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.